Vitamin E Delta Tocotrienol
IPMN, Pancreatic
H. Lee Moffitt Cancer Center and Research InstitutePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the IPMN, Pancreatic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM National Cancer Institute (NCI) | Phase 3 | BB |
Capecitabine National Cancer Institute (NCI) | Phase 3 | BB |
Secretin Fundacion Clinic per a la Recerca Biomédica | Phase 3 | B |
Sulindac Duke University | Phase 2 | CCC |
rg1068 Massachusetts General Hospital | Phase 1 | CC |
Ferumoxytol OHSU Knight Cancer Institute | N/A | D |
ly4337713 Eli Lilly and Company | Phase 1 | NR |
Same molecule, other indications
Vitamin E Delta Tocotrienol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →